Skip to Primary Navigation

Skip to main content

Supermarket pharmacy compliance scrutinized in Washington opioid trial

A photo of a woman with short, gray hair shopping in an aisle below a sign that reads, "Pharmacy Rx."
Photo: Tim Boyle/Getty Images

Kevin Kinsella

2 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Testimony and internal emails reveal limited staffing and oversight as Washington attorney general presses claims of opioid diversion failures.

One of the largest supermarket chains in the North America is facing heightened scrutiny in a Washington state trial over whether its pharmacies failed to prevent opioid diversion, with testimony from former compliance executives highlighting concerns about staffing and oversight.

Two former directors of pharmacy compliance for Albertsons Companies, Jessica

, , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience